Role of Electrophysiological Studies in RVOT Ventricular Tachycardia
Electrophysiological studies (EPS) are reasonable and recommended for diagnostic evaluation in patients with structurally normal hearts who have palpitations or suspected right ventricular outflow tract ventricular tachycardia (RVOT VT). 1
Diagnostic Value of EPS in RVOT VT
EPS serves several critical purposes in the management of RVOT VT:
Precise Diagnosis and Localization:
- EPS is motivated primarily by the need to establish precise diagnosis to guide curative catheter ablation 1
- Activation mapping and/or pacemapping during EPS allows precise localization of the VT origin 1
- Mapping should begin in the RVOT (including pulmonary artery sinus), followed by great cardiac veins, aortic cusps, and endocardial LVOT 1
Mechanism Identification:
- EPS helps differentiate RVOT VT from more serious conditions like arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) 1
- RVOT VT typically demonstrates triggered activity arising from delayed afterdepolarizations 1
- The arrhythmia is frequently adenosine-sensitive and facilitated by catecholamines 1
Induction of Arrhythmia:
EPS as Guide for Ablation Therapy
When medical therapy fails or patients remain symptomatic, EPS plays a crucial role in guiding ablation:
Mapping for Ablation:
- The 2015 ESC guidelines recommend catheter ablation of RVOT VT/PVCs in:
- Symptomatic patients
- Patients with failure of anti-arrhythmic drug therapy
- Patients with LV function decline due to RVOT-PVC burden 1
- The 2015 ESC guidelines recommend catheter ablation of RVOT VT/PVCs in:
Ablation Success Rates:
- Acute success rates for RVOT ablation exceed 95% when performed by experienced operators 1
- Long-term success varies, with recurrence rates of approximately 50% over extended follow-up 2
- Recurrences may have similar morphology (33%) or different morphology (67%) compared to the initially treated arrhythmia 2
Clinical Approach to RVOT VT Management
Based on the evidence, a structured approach to RVOT VT management incorporating EPS includes:
Initial Assessment:
First-line Treatment:
When to Consider EPS and Ablation:
- For patients who:
- Remain symptomatic despite medical therapy
- Are drug-intolerant
- Do not desire long-term drug therapy
- Show LV function decline due to high PVC burden 1
- For patients who:
Post-ablation Follow-up:
- Long-term monitoring is necessary due to potential late recurrences 2
- Recurrent symptoms warrant repeat evaluation
Important Considerations and Pitfalls
Differentiating from ARVD/C:
Limitations of EPS:
Ablation Challenges:
In conclusion, EPS plays a vital diagnostic and therapeutic role in RVOT VT management, particularly in guiding curative catheter ablation, which has become the definitive treatment for drug-refractory cases or patients who prefer not to take long-term medications.